Board Meeting3 Nov 2026, 03:08 pm
Gennex Laboratories Board Meeting on Nov 14 to Adopt Q2 FY27 Results
AI Summary
Gennex Laboratories Ltd has announced a Board of Directors meeting scheduled for November 14, 2026. The primary agenda items include the consideration and adoption of the Unaudited Financial Statements (Standalone and Consolidated) for the Quarter and Half Year ended September 30, 2026. The meeting will also review the Limited Review Reports from the Statutory Auditor on these financial statements. Additionally, the trading window for dealing in the company's securities will reopen 48 hours after the declaration of these financial results.
Key Highlights
- Board meeting scheduled for November 14, 2026.
- To consider and adopt Unaudited Financial Statements for Q2 FY27.
- Review of Statutory Auditor's Limited Review Reports.
- Trading window to reopen 48 hours post results declaration.
Price Impact
More from GENNEX